WHERE ARE NSF'S CHEMISTRY DOLLARS HEADED?

Volume 5, #16The ScientistAugust 19, 1991 WHERE ARE NSF'S CHEMISTRY DOLLARS HEADED This year, the National Science Foundation's chemistry division is asking Congress for a 10 percent increase, or $10 million above FY 1991's $100 million, to offset a trend of the past five years that merely kept the division's budget apace with cost-of-living increases. About half of the increase would be distributed across the board to the organic, inorganic, physical, and analytic subdivision

Written byR. E.
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This year, the National Science Foundation's chemistry division is asking Congress for a 10 percent increase, or $10 million above FY 1991's $100 million, to offset a trend of the past five years that merely kept the division's budget apace with cost-of-living increases.

About half of the increase would be distributed across the board to the organic, inorganic, physical, and analytic subdivisions. Another 3 percent would go to the Materials Synthesis and Processing program, a division-wide, $25 million initiative for basic research into materials science; 1 percent would go to infrastructure development, enhancements in educational programs, and initiatives for minorities and women. The remaining 1 percent would be discretionary.

The final decision by Congress on the total NSF budget should be coming in September. While Congress usually doesn't pick a particular research area to hatchet, it may ask NSF to decrease its total budget. That decrease could trickle down to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies